Skip to content
Screener

Axogen AXGN Shares (Diluted)

Shares (Diluted) at other companies

Baxter International logo
Baxter InternationalBAX
515M+0.2%
Stryker logo
StrykerSYK
386M-0.1%
IAR
Integra LifeSciencesIART
78.2M+1.9%
LeMaitre Vascular logo
LeMaitre VascularLMAT
24.5M+7.2%
Bioventus logo
BioventusBVS
70.8M+3.4%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
40.9M+3.6%

Other financials

Income statement

See full
Revenue$69.7M+23.1%
Gross profit$50.7M+20.6%
Operating income-$2.2M-229%
Net income-$1.5M-362%
EPS (diluted)-$0.03-400%

Balance sheet

See full
Cash & equivalents$96.6M+271%
Total debt$20.1M-70.6%
Total equity$256.3M+128%
Total assets$304.9M+48.4%

Cash flow

See full
Operating cash flow$7.2M
CapEx$893.0K+23.7%
Free cash flow$6.3M

Valuation

See full
Market cap$2.38B+277%
Enterprise value$2.31B+242%
P/S9.5×+6.4×

Profitability

See full
Gross margin74.6%+0.3pp
Operating margin-5.1%
Net margin-13.4%-17.4pp
FCF margin-12.9%-3.8pp

Returns & leverage

See full
Return on equity-18.2%-28.9pp
Debt / equity0.1×-0.5×
Current ratio6.6×+2.5×

Where this comes from

Reported directly by Axogen in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: Axogen’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:13 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000805928-26-000094
Line itemThree Months Ended / June 30, 2026Three Months Ended / June 30, 2025Six Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Change in fair value of debt derivative liabilities480322
Other (expense) income, net(145)179(122)142
Total other income (expense), net640(1,093)(16,112)(3,266)
Net (loss) income$(1,516)$579$(21,100)$(3,255)
Weighted average common shares outstanding - basic53,339,25846,063,09252,562,97645,605,419
Weighted average common shares outstanding - diluted53,339,25847,980,83052,562,97645,605,419
Net (loss) income per common share - basic$(0.03)$0.01$(0.40)$(0.07)
Net (loss) income per common share - diluted$(0.03)$0.01$(0.40)$(0.07)

ITEM 1 — FINANCIAL STATEMENTS

FAQ

What is Axogen's shares (diluted)?
Axogen (AXGN) reported shares (diluted) of 53.3M in Q2 2026.
How has Axogen's shares (diluted) changed year-over-year?
Axogen's shares (diluted) increased by 11.2% year-over-year, from 48M to 53.3M.
What is the long-term trend for Axogen's shares (diluted)?
Over 4 years (2021 to 2025), Axogen's shares (diluted) has grown at a 3.4% compound annual growth rate (CAGR), from 164.5M to 188.3M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about Axogen's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude